Changes in serum phosphate during β‐blockade in healthy men are not due to changes in the renal handling of phosphate

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Changes in serum phosphate during β‐blockade in healthy men are not due to changes in the renal handling of phosphate. / Kayser, L.; Perrild, H.; Jørgensen, B.; Fogh‐Andersen, N.; Hansen, J. E. Mølholm.

I: Journal of Internal Medicine, Bind 225, Nr. 3, 1989, s. 197-200.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Kayser, L, Perrild, H, Jørgensen, B, Fogh‐Andersen, N & Hansen, JEM 1989, 'Changes in serum phosphate during β‐blockade in healthy men are not due to changes in the renal handling of phosphate', Journal of Internal Medicine, bind 225, nr. 3, s. 197-200. https://doi.org/10.1111/j.1365-2796.1989.tb00063.x

APA

Kayser, L., Perrild, H., Jørgensen, B., Fogh‐Andersen, N., & Hansen, J. E. M. (1989). Changes in serum phosphate during β‐blockade in healthy men are not due to changes in the renal handling of phosphate. Journal of Internal Medicine, 225(3), 197-200. https://doi.org/10.1111/j.1365-2796.1989.tb00063.x

Vancouver

Kayser L, Perrild H, Jørgensen B, Fogh‐Andersen N, Hansen JEM. Changes in serum phosphate during β‐blockade in healthy men are not due to changes in the renal handling of phosphate. Journal of Internal Medicine. 1989;225(3):197-200. https://doi.org/10.1111/j.1365-2796.1989.tb00063.x

Author

Kayser, L. ; Perrild, H. ; Jørgensen, B. ; Fogh‐Andersen, N. ; Hansen, J. E. Mølholm. / Changes in serum phosphate during β‐blockade in healthy men are not due to changes in the renal handling of phosphate. I: Journal of Internal Medicine. 1989 ; Bind 225, Nr. 3. s. 197-200.

Bibtex

@article{4bc2af21ed9a4b21a4394b580b84d75f,
title = "Changes in serum phosphate during β‐blockade in healthy men are not due to changes in the renal handling of phosphate",
abstract = "Abstract. Serum parathyroid hormone (PTH), phosphate, ionized calcium, magnesium, alkaline phosphatase and creatinine and the urinary excretion of phosphate and creatinine were studied after 1 and 3 weeks β‐blockade in 32 young healthy men given either atenolol at 50 mg. metoprolol at 100 mg, propranolol at 80 mg or placebo twice a day. After 1 week treatment serum phosphate (mean (range)) increased in the propranolol‐treated subjects (1.17 (0.99–1.30) to 1.32 (1.08–1.71) mmol l−1 (P = 0.03), minor changes were found in the atenolol and the metoprolol‐treated subjects but not in the placebo group. Serum phosphate was unchanged compared to pretreatment values after 3 weeks. Renal clearance and urinary excretion of phosphate and creatinine was unchanged after both 1 and 3‐weeks treatment. Serum PTH, ionized calcium, magnesium and alkaline phosphatase were unchanged in all groups, whereas serum urate and creatinine increased in the metoprolol‐treated subjects after both 1 and 3 weeks. 1989 Blackwell Publishing Ltd",
keywords = "atenolol, calcium, magnesium, metoprolol, placebo, propranolol, PTH, renal phosphate handling, serum phosphate",
author = "L. Kayser and H. Perrild and B. J{\o}rgensen and N. Fogh‐Andersen and Hansen, {J. E. M{\o}lholm}",
year = "1989",
doi = "10.1111/j.1365-2796.1989.tb00063.x",
language = "English",
volume = "225",
pages = "197--200",
journal = "Journal of Internal Medicine",
issn = "0955-7873",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - Changes in serum phosphate during β‐blockade in healthy men are not due to changes in the renal handling of phosphate

AU - Kayser, L.

AU - Perrild, H.

AU - Jørgensen, B.

AU - Fogh‐Andersen, N.

AU - Hansen, J. E. Mølholm

PY - 1989

Y1 - 1989

N2 - Abstract. Serum parathyroid hormone (PTH), phosphate, ionized calcium, magnesium, alkaline phosphatase and creatinine and the urinary excretion of phosphate and creatinine were studied after 1 and 3 weeks β‐blockade in 32 young healthy men given either atenolol at 50 mg. metoprolol at 100 mg, propranolol at 80 mg or placebo twice a day. After 1 week treatment serum phosphate (mean (range)) increased in the propranolol‐treated subjects (1.17 (0.99–1.30) to 1.32 (1.08–1.71) mmol l−1 (P = 0.03), minor changes were found in the atenolol and the metoprolol‐treated subjects but not in the placebo group. Serum phosphate was unchanged compared to pretreatment values after 3 weeks. Renal clearance and urinary excretion of phosphate and creatinine was unchanged after both 1 and 3‐weeks treatment. Serum PTH, ionized calcium, magnesium and alkaline phosphatase were unchanged in all groups, whereas serum urate and creatinine increased in the metoprolol‐treated subjects after both 1 and 3 weeks. 1989 Blackwell Publishing Ltd

AB - Abstract. Serum parathyroid hormone (PTH), phosphate, ionized calcium, magnesium, alkaline phosphatase and creatinine and the urinary excretion of phosphate and creatinine were studied after 1 and 3 weeks β‐blockade in 32 young healthy men given either atenolol at 50 mg. metoprolol at 100 mg, propranolol at 80 mg or placebo twice a day. After 1 week treatment serum phosphate (mean (range)) increased in the propranolol‐treated subjects (1.17 (0.99–1.30) to 1.32 (1.08–1.71) mmol l−1 (P = 0.03), minor changes were found in the atenolol and the metoprolol‐treated subjects but not in the placebo group. Serum phosphate was unchanged compared to pretreatment values after 3 weeks. Renal clearance and urinary excretion of phosphate and creatinine was unchanged after both 1 and 3‐weeks treatment. Serum PTH, ionized calcium, magnesium and alkaline phosphatase were unchanged in all groups, whereas serum urate and creatinine increased in the metoprolol‐treated subjects after both 1 and 3 weeks. 1989 Blackwell Publishing Ltd

KW - atenolol

KW - calcium

KW - magnesium

KW - metoprolol

KW - placebo

KW - propranolol

KW - PTH

KW - renal phosphate handling

KW - serum phosphate

U2 - 10.1111/j.1365-2796.1989.tb00063.x

DO - 10.1111/j.1365-2796.1989.tb00063.x

M3 - Journal article

C2 - 2649632

AN - SCOPUS:0024584387

VL - 225

SP - 197

EP - 200

JO - Journal of Internal Medicine

JF - Journal of Internal Medicine

SN - 0955-7873

IS - 3

ER -

ID: 335354164